Willow Bioscience eyes another use for BioOxi platform with R&D of ursodeoxycholic acid
–News Direct– Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to announce some significant developments within the company. Willow Bioscience specializes in the production of ursodeoxycholic acid…